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SUMMARY 
 
The Escherichia coli Ig-binding (Eib) proteins are trimeric autotransporter adhesins 
(TAAs) and receptors for IgG Fc. We present the structure of a large fragment of the 
passenger domain of EibD, the first TAA structure to have both a YadA-like head 
domain and the entire coiled-coil stalk. The stalk begins as a right-handed superhelix, 
but switches handedness halfway down. An unexpected, novel -minidomain joins 
the two and inserts a ~120° rotation such that there is no net twist between the 
beginning and end of the stalk. This may be important in folding and autotransport. 
The surprisingly large cavities we found in EibD and other TAAs may explain how 
TAAs bend to bind their ligands. We identified how IgA and IgG bind and modelled 
the EibD-IgG Fc complex. We further show that EibD promotes autoagglutination 
and biofilm formation and forms a fibrillar layer covering the cell surface making 
zipper-like contacts between cells.  
 
Highlights:  
o The first TAA structure containing both a head domain and a complete stalk 
o A -minidomain mediates the change from right-handed to left-handed 
supercoiling 
o The binding sites for IgG and IgA are in the stalk 




Trimeric autotransporter adhesins (TAAs) are a family of virulence-related, secreted 
proteins in Gram-negative bacteria that form the type Vc secretion pathway (Dautin 
and Bernstein, 2007; Linke et al., 2006). They are all obligate homotrimers, and the 
conserved C-terminal sequence forms the translocation unit consisting of a 12-
stranded -barrel outer membrane anchor and an -helical linker (Meng et al., 2006). 
The more varied N-terminal portions, the passenger domains, are secreted into the 
extracellular space, and typically consist of a globular head domain connected to the 
anchor by a coiled-coil stalk (Hoiczyk et al., 2000).  
 
The immunoglobulin (Ig)-binding proteins from E. coli (Eibs) are a subgroup of 
TAAs. Though first detected in commensal strains (Sandt et al., 1997), they are 
relatively common in intimin-negative, shiga toxin-producing enterohaemorrhagic E. 
coli (EHEC) strains (Merkel et al., 2010). The group currently comprises six 
characterised members: EibA, EibC, EibD, EibE, EibF, EibG and EibH (Sandt and 
Hill, 2000; Sandt and Hill, 2001; Lu et al., 2006; Merkel et al., 2010) (we use the 
notation EibACDEFG to designate multiple members of the group). The Eibs are 
receptors for IgAs and IgGs and bind to the Fc portion of Igs non-immunologically 
(Leo and Goldman, 2009). They also increase the serum resistance of the bacteria and 
are involved in adherence to epithelial cells (Sandt and Hill, 2000; Sandt and Hill, 
2001; Lu et al., 2006). We have shown that the Eibs bind IgG Fc with affinities in the 
100 nM range (Leo and Goldman, 2009), while only EibCDFG (i.e. not EibAE) bind 
IgA with affinities between 70 nM (EibF) and 500 nM (EibC) (Sandt and Hill, 2001; 
Lu et al., 2006; Leo and Goldman, 2009).  
 This study presents, in two overlapping parts, the crystal structure of the head and 
stalk (residues 161-418 and 391-440) of the EibD passenger domain. This region, 
containing the binding activity towards both IgG and IgA, consists of a YadA-like -
roll (Nummelin et al., 2004) followed by the extended coiled-coil stalk connecting the 
head to the membrane anchor. It is the first example of a head domain combined with 
a complete stalk and includes the striking transition from right-handed to canonical 
left-handed supercoiling characteristic of many TAA stalks (Hernandez Alvarez et al., 
2010). By detailed mutagenesis analysis, we have pinpointed the IgG and IgA-binding 
activities in the stalk. Staphylococcal protein A (SpA) could block EibD binding to 
IgG Fc, suggesting that they bind to the same region of IgG Fc. This has allowed us to 
model the complex. The model suggests that EibD can simultaneously bind up to 
three IgG molecules, which is in good agreement with experimental results. We 
further examined the expression of EibD on the cell surface by electron microscopy 
(EM) and demonstrated two new activities for EibD suggesting a role for the Eibs in 
virulence: autoagglutination and biofilm formation. 
RESULTS 
 
Structure of EibD161-440. We crystallised two overlapping fragments of EibD, 
EibD161-418 and EibD391-440, as described in more detail in Supplemental Experimental 
Procedures. The smaller fragment was produced with GCN4 adaptor sequences at 
either end to promote stable trimerisation (Hernandez Alvarez et al., 2008). Rwork/Rfree 
for the two structures were 15.9/19.6% and 26/30.8% (Table 1). 
 
EibD161-440 is an elongated lollipop-like structure with a globular head domain, a neck 
and an extended stalk (Figure 1A; see Figure S1A for a stereo image). The N-terminal 
part of EibD161-440 is a left-handed parallel -roll (LPBR) domain very similar to the 
head of YadA (Figure S1B). In YadA, the LPBR consists of repeats with the 
consensus motif NSVAIGXXS (Nummelin et al., 2004), and EibA has eight such 
repeats (Figure 1). These motifs have a dual structural role, forming both the 
hydrophobic core of the -roll itself as well as the shared hydrophobic core of the 
trimer (Nummelin et al., 2004). However, in contrast to YadA, the EibA motifs have 
the consensus sequence XSTALGXXA (Figure S1C). A further difference is the large 
loop protruding from EibD between the last two LPBR repeats (Figure S1B). This 
loop is a part of the neck, a connecting element between the LBPR domain and the 
stalk (Nummelin et al., 2004) that rotates the rest of the polypeptide by 120° 
clockwise (Figure S1D) so that the following helix in the stalk is located directly 
beneath the adjacent monomer.  
 
The N-terminal part of the stalk is a right-handed coiled-coil (RHcc) with hendecad 
periodicity, i.e. 11 residues per three turns (Lupas and Gruber, 2005). It terminates in 
a -sheet minidomain (residues 350-371) that we call the saddle (Figure 1). The 
saddle is followed by a canonical left-handed coiled-coil (LHcc) with heptad 
periodicity (3.5 residues per turn). The saddle is responsible for a second 120  
rotation that is in the opposite direction to the one introduced by the neck (Figure 
S1E). The saddle is only 22 residues long and consists of three anti- -sheets, 
without any significant similarity to other known structures. Its presence was not 
obvious from sequence analysis, as the residue pattern is compatible with a 
continuous structure that retains coiled-coil periodicity. The saddle is stabilized by an 
-
region (Nummelin et al., 2004).  
 
The core of the LHcc is surprisingly hydrophilic. It contains five chloride ions, a 
water molecule and three glutamines that point inwards. In four cases, the chloride is 
coordinated by asparagine residues in position d of the coiled-coil heptad (the seven 
positions of the heptad are designated a-g) (Figure S1F). Though hydrophobic 
residues are normally expected, Asn in the d d
trimeric autotransporters (Hartmann et al., 2009), and binds anions in both SadA 
(Hartmann et al., 2009) and UspA1 (Conners et al., 2008). Novel hydrophilic motifs 
in the EibD stalk are the fifth chloride, which is coordinated by threonine residues in 
an RTD motif where the T is in position a (Figure S1G), the water molecule 
coordinated by H421 in position d (Figure S1H), and the Q428s at position d that 
form a three-way hydrogen bond (Figure S1I). RxD motifs are relatively common in 
LHccs of TAAs and form polar networks at the interfaces between monomers 
(Hernandez Alvarez et al., 2010). Usually, the middle position (a in the coiled-coil) is 
occupied by a hydrophobic aliphatic residue, so threonine in this position is somewhat 
surprising. In EibD, in addition to the chloride-coordinating 382RTDRID387 motif, 
there are two more RxD motifs between residues 393-397 and 421-426, the second 
including H421. In RHccs, YxD motifs play an analogous role to RxD, with threonine 
commonly in the middle position (Hernandez Alvarez et al., 2010). There are two 
YxD motifs in the RHcc: 317YDDVK321 and  334YTDQK338. YxD motifs normally 
bracket the l position of pentadecad coiled-coils, but in EibD the middle residue of the 
second YxD is in the a position, the geometric equivalent in hendecad coiled-coils. 
Surprisingly, the core residue of the first motif (V) is between the second D and K, in 
position h. In contrast to the usual Yx(l)D arrangement, abundant in TAA stalks 
(Szczesny and Lupas, 2008), this second configuration is rare.  
 
In addition to the water- and chloride-binding cavities in the LHcc, there are others in 
both the right- and left-handed part of the stalk. Most of these are small (solvent-
3), but two are significantly larger, with solvent-accessible 
volumes of 11 Å3 and 46 Å3 (calculated using the CASTp server (Dundas et al., 
2006)). Both large cavities, located in the RHcc (Figure 1C), are lined by hydrophobic 
groups and devoid of any extra electron density at one . We discuss the potential 
implications of this for function below. 
 
Immunoglobulin binding studies. EibD161-418 bound both IgA and IgG (Figure 
S2A). To map the Ig-binding regions more precisely, we produced four C-terminal 
truncations of EibD161-418 and a number of double and triple point mutants, where 
surface residues were changed to alanine (Table 2). Ig binding to all of the point 
mutants was measured by dot blot and by surface plasmon resonance (SPR), and 
conformational changes were monitored by far-UV circular dichroism (CD) 
spectroscopy (Figure S2C). 
 
The truncations indicate that the binding site for IgG is at the C-terminus of the stalk 
between residues 384 and 418, and that the binding site for IgA lies between residues 
329 and 344 (Figure S2B). Among the point mutants (Table 2) we included some 
residues outside the putative binding sites, as it was also possible that the truncations 
deleted only part of the binding regions. Qualitatively (Figure 2A), it is clear that 
mutant K332A-K333A-Y334A had a severe effect on IgA binding, practically 
abolishing the signal. The only mutant to have a large effect on IgG binding was 
D387A-Y388A. 
 
The apparent affinities for Ig (Kd(app)) determined for the mutants by SPR were 
mostly similar to wild type (wt), i.e. 50-100 nM for IgG and 100-200 nM for IgA 
(Table 2). However, we were unable to estimate a reliable Kd(app) for the mutant 
K332A-K333A-Y334A binding to IgA (Figure 2B). For D387-Y388, we obtained an 
Kd(app) of 288 nM for IgG. This, however, cannot be considered a reliable estimate, 
because of the peculiar shape of the curves, which are far from equilibrium (Figure 
2B). The true affinity is therefore likely lower. These results are consistent with the 
results from the dot blots, suggesting that these mutations have a deleterious effect on 
the binding sites for IgA and IgG, respectively. These mutants also abolished binding 
to the respective Igs (IgA for K332A-K333A-Y334A and IgG for D387A-Y388A) 
when expressed on the cell surface (Figure S3B). The Kd(app) for the T415A-R416A-
T17A mutant had a large SEM, but it also bound weakly by dot blot and had a 
somewhat altered CD spectrum (Figure S2C), suggesting that it causes some subtle 
structural change that may be propagated along the coiled-coil. These data show that 
IgA and IgG binding have separate binding sites on the coiled-coil, one in the RHcc 
and the other in the LHcc. 
 
To determine the role of the saddle in Ig binding, we produced two deletion mutants: 
350-372 and 352-372. The first retains the periodicity of the coiled-coil, while the 
second introduces a two-residue insertion, which could cause more prominent 
structural alterations (Lupas and Gruber, 2005). Neither deletion caused any major 
conformational changes, though 352-372 had a larger effect than 350-372 (Figure 
S2C). 350-372 seemed to improve binding to Igs and 352-372 was comparable to 
the wt by dot blot (Figure 2A)  but both weakened binding in the SPR experiments 
(Table 2, Figure 2B). The most likely explanation for this paradox is the differences 
in experimental set up: in the dot blot experiments, the EibD derivatives were 
immobilised, whereas in the SPR assays the antibodies were. The lack of the saddle 
may destabilise the structure of the EibD stalk, consistent with our earlier results 
showing that the stalk alone binds poorly to Igs (Figure S2). If the stalk is to some 
degree labile, as suggested by sensitive size exclusion chromatography coupled to 
static light scattering and refractive index measurements (Figure S2E), the absence of 
the saddle may cause the coiled-coil to have a heightened tendency to dissociate in 
solution. Immobilising the stalk deletion mutants would stabilise the coiled-coil. 
 
Model of EibD binding to Fc. SpA and streptococcal protein G (SpG) are IgG-
binding proteins which both target the same epitope: the exposed connector between 
the constant domains CH2 and CH3 in IgG Fc (Tashiro and Montelione, 1995). We 
showed (Figure 3A) that SpA had a concentration-dependent inhibitory effect on the 
binding of HRP-labelled IgG to immobilised EibD and SpG, suggesting that EibD 
also binds to the same site in IgG Fc. SpA is a three-helix bundle, and the stalk of 
EibD is similarly composed of three helices. Therefore, we modelled EibD bound to 
IgG Fc based on the SpA-Fc crystal structure (Figure 3B). The model suggests that 
the EibD IgG binding site could accommodate the connector region of Fc. 
Furthermore, three molecules of Fc can bind to EibD simultaneously (Figure 3C), 
consistent with previous experimental data, which suggested Eibs can bind at least 
two IgGs at the same time (Leo and Goldman, 2009).  
 
EibD expressed on the cell surface. In transmission electron micrographs (TEM), 
EibD-expressing cells clearly show an additional layer on the cell surface (Figure 4, 
upper panel). This is reminiscent of YadA, which also coats the cell at high density 
-
headgroups and the outer membrane (Hoiczyk et al., 2000). In scanning electron 
micrographs (SEM), the surface of EibD-expressing bacteria appeared ruffled, in 
contrast to the smooth surfaces of control cells (Figure 4, lower panel insets).  
 
When culturing EibD-expressing bacteria, we noticed that they tended to flocculate 
(Figure 5A). Autoagglutination is typical for YadA and other TAAs (Linke et al., 
2006). To show quantitatively that EibD mediates autoagglutination, we measured the 
reduction in optical density at the surface of static cultures (Figure 5B). EibD-
expressing bacteria settled rapidly at the bottom of the tubes, whereas the vector 
control culture remained turbid for much longer. The self-associating activity of EibD 
was also evident in electron micrographs (Figure 4). The cell surface protrusions form 
tight zipper-like contacts (Figure 4, upper panel inset, and Figure S3A), similar to the 
arrangement seen for autoagglutinating YadA (Hoiczyk et al., 2000). These contacts 
were strong enough to tear off outer membrane fragments from neighbouring cells 
leading to lysis (upper panels in Figure 4 and Figure S3A). In SE micrographs, the 
EibD-expressing bacteria clearly formed aggregates (Figure 4, lower panels). We 
believe that EibD also promotes aggregation under physiological conditions as well, 
as EibG has been shown to mediate chain-like aggregation (Lu et al., 2006). 
 
Aggregation and adhesion are among the first steps in biofilm formation (Dunne, 
2002). We therefore tested whether EibD could mediate the formation of biofilms 
when expressed at the cell surface. In a crystal violet staining assay, EibD expression 
led to intense staining of adherent bacteria, whereas the vector control was barely 
above background (Figure 5C). EibD - and presumably other Eibs like EibG - does 
promote the formation of biofilm, which may be biologically important.  
 
Comparison of EibD with other members of the Eib family. Alignment of the Eib 
sequences (Figure 6) shows that the saddle is conserved in all Eibs, as is the LHcc 
containing the IgG binding site (Figure 6A). Interestingly, Ala frequently replaces the 
Tyr (Y388 in EibD) at the IgG binding site, suggesting that the crucial residue for 
binding is the completely conserved D387. In EibCD, the IgA and IgG binding sites 
are situated relatively close to each other (~50 Å), explaining why we observed that 
IgG binding interferes with IgA binding (Leo and Goldman, 2009).  
 
The IgA binding regions of EibCD are identical (Figure 6B). Intriguingly, a region 
with 80% identity is present in EibEG, though EibE does not bind IgA (Sandt and 
Hill, 2001). However, the IgA binding motif 332KKY334 of EibCD is replaced by REY 
in EibEG. The change K E is presumably why EibEG bind IgA very poorly (Sandt 
and Hill, 2001; Lu et al., 2006).  
 
Conversely, the IgA binding motif KKY is similar to a previously identified repeat in 
EibF, which contains the sequence NKY (Figure 6B) (Sandt and Hill, 2001). This is 
also consistent with the central K being essential for IgA binding and explains why 




TAA architecture and the mechanism of bending. All of the current TAA 
structures are of pieces; this is the first one to contain both a head domain and a 
complete stalk. It validates our earlier work (Hernandez Alvarez et al., 2008) that 
structures of individual fragments of TAA head domains and stalks can be combined 
to generate a complete model  if the granularity of the fragments is correct. 
However, it also shows the limits of such an approach; you find only what you expect 
to find. The switch from a RHcc into a left-handed one in EibD was expected to be 
continuous as in YadA (Hernandez Alvarez et al., 2010), where the transition 
proceeds via local unwinding of the supercoil. There was no sequence evidence for 
the saddle; we would not have been aware of its existence had we not solved the 
entire structure.  
 
IgA or IgG, though deleting it does have some effect (Table 2; Figure 2). An 
intriguing feature of the region (Figure 1) is that the ~120° rotation is in the opposite 
sense to that imposed by the neck. As a result of this and of the equivalent 
superhelical twists of the right-handed and left-handed regions, there is essentially no 
twist between the top and bottom of the stalk. This may be an advantage in folding, if 
the passenger domain, as is generally believed, has to pass through the constricted 
pore of the -barrel translocator domain (Dautin and Bernstein, 2007). Overall, there 
are two 120° rotations of opposite hand in the EibD structure (Figure 1); the YadA 
head-stalk (Nummelin et al., 2004) has exactly the same arrangement, but with the 
rotations above the LPBR and in the neck region. Having an even number of 
opposite-handed 120° rotations could reduce torsional strain during autotransport and 
folding because there would be no superhelical twisting that would have to be 
unwound by counter-rotation of the barrel in the membrane. 
 
TAAs are extended, rod-like structures, and bending of TAAs appears to be important 
for function. The stalk of UspA1 is deformable (Conners et al., 2008); kinks and 
bends are seen in electron micrographs of EmaA and BadA (Szczesny et al., 2008; Yu 
et al., 2008); and bending has been postulated to be important in the binding of YadA 
to collagen (Nummelin et al., 2004) and of Hia to its cellular receptor (Meng et al., 
2008). The question is, how? To our surprise, we noticed a large number of cavities in 
the EibD stalk, two of them of significant size (>10 Å3 accessible-surface volume). 
We therefore examined the only other TAA stalk structures, UspA1 (2QIH; Conners 
et al., 2008) and YadA (3H7X; Hernandez Alvarez et al., 2010; Koretke et al., 2006). 
Both contained large cavities: the proposed bending site of UspA1 is at the stutter in 
the coiled-coil stalk (Conners et al., 2008), and there is a 78 Å3 cavity at this position. 
YadA has a 14 Å3 cavity at the RHcc to LHcc transition (three times the volume of 
the largest cavity in the EibD saddle.) We propose that deformability induced by 
cavities may be a universal mechanism used by TAAs to allow bending. The result 
also implies that different TAAs bend at different places. 
 
Ig binding and biological implications. The binding of IgG by SpA and SpG 
prevents the activation of the classical pathway of complement by blocking the Fc 
binding site for C1q (Lambris et al., 2008; Nitsche-Schmitz et al., 2007). Fc binding 
by Eibs presumably performs the same function and contributes to serum resistance. 
The serum resistance activity of YadA maps to the coiled-coil stalk (Biedzka-Sarek et 
al., 2008), and the stalks of other trimeric autotransporters also may harbour 
protective activities against host defences (Linke et al., 2006), suggesting this is 
optimal position for protecting the bacterium. Our model of the EibD:Fc complex 
shows that three Fc monomers can bind to EibD simultaneously, consistent with 
previous data (Leo and Goldman, 2009). This is also only the second example where 
there has been enough structural and interaction data to propose a model for how a 
TAA might interact with its cognate ligand, the previous one being YadA bound to a 
collagen-like peptide (Nummelin et al., 2004; Leo et al., 2010). In contrast to YadA, 
where the collagen-binding activity is located in the LPBR domain, our EibD:Fc 
complex model is the first to show binding in the stalk. The model has various 
plausible interactions, chief of which is that sidechain rotations alone of Fc H310 and 
H435 bring them within 4-5 Å of the conserved EibD D387 (Figure 3D).   
 
Biological function of Eibs. Binding of Igs, autoaggregation and biofilm formation 
all suggest that Eibs are virulence factors. Five of the characterised members of the 
group are from apparently harmless commensal ECOR strains (Sandt and Hill, 2000; 
Sandt and Hill, 2001), and as yet uncharacterised eib genes have been detected in 
other commensal E. coli strains (e.g. ED1a; Touchon et al., 2009). In these strains, the 
eib genes are located in prophage sequences (Sandt and Hill, 2000). The commensal 
strains may thus act as a reservoir for these potential virulence factors from which the 
genes, possibly after recombination to produce new TAA variants, are passed on to 
more pathogenic strains. The properties conferred by Eibs would be advantageous for 
commensal strains as w
promote stable colonisation of the host intestinal tract. 
 
Consistent with this idea, eib genes occur in pathogenic and multidrug-resistant E. 
coli strains (Bardiau et al., 2010; Touchon et al., 2009; Fricke et al., 2008). EibG is 
present in 15% of eae-negative EHEC strains (Merkel et al., 2010). It mediates an 
unusual chain-like adhesion phenotype (Lu et al., 2006) that has been suggested to 
contribute to persistence in the host (Merkel et al., 2010). In addition, the 
conservation of IgG binding in particular also implies that the selection pressure on 
the Eib family has been exposure to serum  and consequently that they are virulence 
factors. EibD shares 58-62% sequence identity with the various EibG variants 
(Merkel et al., 2010), so our results provide a first structural model for a non-fimbrial 
adhesin of EHEC O:91 strains. Experimental validation of our EibD:Fc model, as 
well investigation of the mechanism of EibG in EHEC, are our chief goals. 
EXPERIMENTAL PROCEDURES 
 
Cloning and mutagenesis of EibD constructs, protein expression and 
purification. The cloning, production and expression of the full-length EibD 
passenger domain (EibD27-441) have been described before (Leo and Goldman, 2009). 
Cloning, production and purification of other EibD fragments was carried out using 
standard procedures as detailed in Supplemental Experimental Procedures. Mutants 
were produced using the QuikChange® protocol from Stratagene. Primer sequences 
are listed in Table S1. 
 
Crystallisation and data collection. Crystallisation of the fragment EibD161-418 
(which bound both IgA and IgG (Figure S1) and included the YadA-like region) was 
performed by vapour diffusion at 20 C. For initial screening for crystallisation 
conditions for EibD161-418, crystallisation drops of 200 nl (100 nl of protein solution 
and 100 nl of well solution) were set up using a Cartesian Microsys nanopipettor. The 
screens used were modifications of commonly used sparse matrix screens (Helsinki 
Random Screens I & II; 
http://www.biocenter.helsinki.fi/bi/xray/automation/services.htm). For optimisation, 
we constructed grids around the most promising initial hit conditions and set up drops 
of 500 nl (250 nl protein solution plus 250 nl well solution). EibD161-418 (concentrated 
to 10 mg/ml) crystallised readily in many conditions, and the best crystals came from 
1 M ammonimum phosphate containing 0.1 M sodium citrate at pH 5.6. For 
optimisation, we constructed grids around the most promising initial hit conditions 
and set up drops of 500 nl (250 nl protein solution plus 250 nl well solution). For data 
collection, glycerol was added to the well solution to 10% (v/v) and this solution was 
used to cryoprotect the crystals when vitrifying in liquid nitrogen. Although the 
crystals were small (~100 m in the largest dimension), they diffracted to 2.0 Å at the 
European Synchrotron Radiation Facility (ESRF). The structure was solved by 
molecular replacement using YadA (PDB ID: 1P9H) as the search model.  
 
For the GCN4-EibD391-440 fusion protein, crystallization trials of EibD391-440 were 
performed at 22 C with 384 conditions by mixing 400 nl of reservoir solution with 
400 nl of protein solution at a concentration of 2 mg/ml on Corning 3550 96-well 
sitting drop plates, using a Honeybee 961 crystallization robot (Genomic Solutions). 
This fragment crystallised in 20% isopropanol containing 200 mM sodium citrate and 
100 M HEPES at pH 7.5. For cryoprotection, crystals were transferred into drops 
containing 25 % (v/v) glycerol in addition to the reservoir solution, loop-mounted and 
vitrified in liquid nitrogen. Datasets of different cystals were collected at beamlines 
X10SA and X06DA of the Swiss Light Source (Paul Scherrer Institute, Villigen, 
Switzerland) at 100 K. All crystals were strongly anisotropic with diffraction limits of 
up to 2.1 Å along the c axis but at best 2.7 Å along a and b. The dataset used for 
structure solution and refinement was collected on a mar225 CCD detector 
(Marresearch) at the beamline X06DA. 
 
Data processing, structure solution and refinement. For EibD161-418, the images 
were processed in Mosflm (Leslie, 1992) and analysed with the programme Pointless 
in CCP4 version 6.1.1 (1994). Afterwards the data were scaled in Scala (Evans, 2006) 
of the CCP4 program suite.  
 
Initial molecular replacement was done with the CaspR web server (Claude et al., 
2004) using YadA (1P9H) (Nummelin et al., 2004) as the search model, and manual 
model building was done in Coot (Emsley and Cowtan, 2004) with refinement rounds 
performed in REFMAC (Vagin et al., 2004). The final refinement round and 
automated water picking were performed in Phenix (Adams et al., 2002). The 
structure quality was assessed with Molprobity (Davis et al., 2004). 
 
For GCN4-EibD391-440, data were processed and scaled to 2.8 Å using the XDS 
program suite (Kabsch, 1993). The crystals belong to space group P321, with one 
monomer in the asymmetric unit. The structure was solved by molecular replacement 
using the program MOLREP (Vagin and Teplyakov, 2010) and a trimmed monomer 
of the SadAK3 structure 2WPQ (Hartmann et al., 2009) as a search model. The 
structure was completed in cyclic manual modeling with Coot (Emsley and Cowtan, 
2004) and refinement with REFMAC5 (Murshudov et al., 1999). All residues of the 
final model fall into the right handed alpha helix core region in the Ramachandran 
plot. 
 
Binding and blocking experiments. Dot blot experiments were carried out 
essentially as described before (Leo and Goldman, 2009). SPR experiments were 
conducted according to standard procedures. To determine apparent dissociation 
constants, we analyzed the binding responses using a steady-state affinity model. For 
blocking experiments, we immobilised EibD27-441 or SpG onto microtiter plate wells. 
We then added horseradish peroxidase-conjugated IgG that had previously been 
incubated with varying concentrations of SpA. To detect bound IgG, we added 
substrate solution and measured absorbance at 450 nm and compared the responses to 
wells with no added SpA. Details of SPR and blocking experiments are given in 
Supplemental Experimental Procedures. 
 
EM, autoagglutination and biofilm formation assays. For TEM, bacteria were 
high-pressure frozen, freeze-substituted and embedded in Epon. The sectioned 
samples were imaged using a FEI Tecnai F20 electron microscope. For SEM, fixed 
bacteria were coated with gold/palladium and imaged using a Hitachi S-800 scanning 
electron microscope. Biofilm formation was assayed using crystal violet staining. We 
followed autoagglutination by measuring the OD600 at the surfaces of static cultures. 
Full details are given in Supplemental Experimental Procedures. 
 
Molecular modelling. The model of the EibD161-511 was built by structure-based 
alignment of overlapping amino acid fragments of the available crystal structures and 
the theoretical model of the EibD membrane anchor. The membrane anchor model 
was generated automatically by the SWISS-MODEL server 
(http://swissmodel.expasy.org) (Arnold et al., 2006) based on the crystal structure of 
the Hia transmembrane domain (3EMO). The overlapping segments were identified 
by external alignment of the amino acid sequences. Finally, the model was 
constructed by structure-based alignment and stepwise extension in the program 
PyMOL. In order to generate single polypeptide chains, overlapping ends were 
trimmed with the preference being given to the experimentally determined structures.  
 
The EibD-IgG Fc model was constructed based on the crystal structure of the human 
Fc fragment in complex with fragment B of SpA (1FC2). The C  atoms of the a-
helical part of SpA were aligned with an equal number of C  atoms of the putative 
IgG binding site from EibD. The EibD-IgG Fc monomer model was then generated 
by removal of the SpA structure. The functional trimers of the EibD model and EibD-
Fc complex were then generated by applying symmetry operators derived from the 
EibD161-418 crystal structure. 
 
ACCESSION NUMBERS 
Atomic coordinates and structure factors have been deposited in the PDB with the 
accession numbers 2XQH (EibD161-418) and 2XZR (GCN4-EibD391-440). 
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Name  EibD 161-418  GCN4-EibD 391-440  
Space group 
(number) 
H 3 (146) P 3 2 1 (150) 
Unit cell [Å] a=b=48.95, c=409.60 a=b=36.67, c=228.58 
Data collection   
Wavelength [Å] 1.039 1.000 
Resolution limits 
[Å] 
41.51-1.99 (2.04-1.99) 38.10-2.80 (2.97-2.80) 
Completeness [%] 97.9 (96.7) 98.8 (99.1) 
Observations   
Total 80792 (5554) 13879 (2188) 
Unique 24632 (1838) 4931 (750) 
Redundancy 3.3 (3.0) 2.8 (2.9) 
I/ (I) 29.16 (4.98) 9.77 (4.09) 
Rmerge [%] 3.4 (12.2) 7.4 (25.1) 
Rmeas [%] 6.0 (22.3) 9.1 (30.7) 
Refinement   
R cryst 0.1585 0.2600 
R free 0.1855 0.3080 
R free test set size 
[%] 
5.0 11.0 
R free set count 1232 541 
Final structure   
RMSD from ideal:   
Bond length [Å] 0.008 0.013 
Bond angle 1.027 1.061 
Chirality 0.070 0.051 
Planarity 0.003 0.004 




Favoured [%] 97.7 100.0 
Outliers [%] 0.8 0.0 




















Table 2  
Apparent affinities (in nM  standard error of the mean) of EibD161-418 mutants to IgA 
and IgG as measured by SPR 
Mutant IgA IgG 
EibD161-418 89  23  54  7 
E327A-E329A-K330A 70  14 146  48 
K332A-K333A-Y334A > 600 85  15 
D336A-K338A 187  33 87  11 
E341A-E344A 86  15 119  21 
D384A-R385A 169  42 109  23 
D387A-Y388A 184  65 288  53  
D394A-R396A 99  27 62  6 
R399A-T401A-Q402A 156  18 58  1 
E405A-K406A 181  20 95  6 
S408A-K409A 250  41 171  25 
T415A-R416A-T417A 456  260 242  96 
350-372 504  65 485  12 





Figure 1. Structure of EibD. The experimental structures of EibD161-418 and the 
EibD391-440 are shown in ribbon representation with the three monomers coloured 
differently. The smaller fragment (EibD391-440) is demonstrated by one monomer in 
brown (GCN4 adapters (Hernandez Alvarez et al., 2008) omitted for clarity). The 
experimental structures were aligned in the overlapping fragment (residues 391-418, 
in red) with an RMSD of 0.243 Å (145 atoms). The chloride ions in the stalk are 
shown as green spheres, and the water oxygen as a red sphere. B) The EibD saddle 
(residues 350-371) showing the ionic and hydrogen bonding network stabilising the 
structure. C) Cavities (the two largest highlighted in yellow circles) in the RHcc. Two 
monomers are shown in space-filling representation. All figures were prepared with 
PyMOL (Schrödinger Corp.). See also Figure S1. 
 
Figure 2. Effect of double and triple point mutations and saddle deletions on the Ig-
binding activities of EibD161-418. A) Dot blot of point and deletion mutants using IgG 
Fc-HRP and IgA-HRP. B) Representative sensorgrams for the binding of EibD161-418 
and mutants to IgG and IgA. Curves for the wt, two point mutants (K332A-K333A-
Y334A and D387A-Y388A) and the saddle deletion mutant 352-372 are shown. In 
addition, the fitting of the data to the one-site affinity model is shown below the 
sensorgrams. See also Figure S2. 
 
Figure 3. Binding of EibD to IgG Fc. A) Blocking of antibody binding to EibD by 
SpA. Wells of a microtitre plate were coated with either EibD (solid line) or SpG 
(dashed line). HRP-conjugated IgG diluted into solutions containing SpA at the 
indicated concentrations was added to the wells and binding detected using TMB 
substrate. The binding level is shown as a percentage of the signal given by antibody 
incubated without SpA. B) Model of EibD (blue/gray) bound to IgG Fc (orange). The 
EibD model contains the experimental structure (residues 161-440) and a homology 
model of the membrane anchor (residues 441-511). IgG Fc monomers were docked 
onto the EibD structure based on the mutagenesis and blocking experiments. See 
Experimental Procedures for details. C) The EibD:IgG Fc complex model viewed 
from the N-terminus of EibD. This view demonstrates that three IgG Fc monomers (I, 
II, III), each containing two domains, can be accommodated around the EibD 
structure without steric hindrance. The colouring is the same as for panel B. D) Close-
up of the binding interface showing histidines 310 and 435 of Fc close to D387 of 
EibD (4.7 Å and 6.0 Å in this configuaration, respectively). EibD is in blue, IgG Fc in 
yellow. 
 
Figure 4. Electron micrographs. The upper panel shows TEM images of cell sections 
and the lower panel SEM images of whole cells. The images show control 
BL21(DE3)omp8 cells containing the vector pET22 or BL21(DE3)omp8 cells 
(Prilipov et al., 1998) expressing full-length wild type EibD (pEibD9; this constuct 
includes an N-terminal His tag) or control cells. Insets show selected regions at higher 
magnification. Expression of EibD leads to clumping of cells, altered surface 
morphology and the formation of zipper-like contacts between cells (inset, top panel). 
See also Figure S3. 
 
Figure 5. EibD-conferred surface properties. A) Photograph of a 3-hour static culture 
of EibD-expressing bacteria (left tube), showing strong autoagglutination. The control 
tube is on the right. B) Quantitative autoagglutination assay. BL21(DE3)omp8 
(Prilipov et al., 1998) expressing EibD (pEibD10, continuous curve) and the vector 
control (pET22, dashed curve) were grown statically after IPTG induction and the 
OD600 value at the surface of the culture measured at 15 minute intervals. C) Biofilm 
formation assay. Adherent bacteria were stained with crystal violet, the dye was 
released from the cells with ethanol, and the absorbance at 595 nm was recorded. The 
autoagglutination and biofilm formation assays were performed on three independent 
cultures. 
 
Figure 6. Comparison of Eib Ig-binding regions. A) Alignment of the C-terminal half 
of the Eib stalks, including the saddle and the left-handed coiled-coil. Conserved 
residues are coloured yellow (saddle) or green (coiled-coil). The a and d positions of 
the heptad periodicity are indicated, as are the secondary structure elements based on 
the EibD structure. The positions of chlorides in the core of the coiled coil are shown 
with red circles; the critical IgG binding residues are marked with green stars. B) 
Alignment of the right-handed region of the EibCDEFG stalks. The a, d and e 
positisions of the hendecad periodicity of the coiled-coil based on the EibD structure 
are shown. The EibF repeats (Sandt and Hill, 2001) are shown in purple. Conserved 
residues in the repeats are also coloured purple. The position of the KKY motif of 
EibD is marked with purple triangles. Similar motifs in repeats 1 and 2 of EibF are 
marked with yellow triangles. Conserved residues outside the repeats are shown in 
cyan. The alignments were generated in ClustalW (Larkin et al., 2007) and manually 
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Figure S1, related to Figure 1. Structural features of EibD. A) Stereo image of EibD161-
440. The colouring of the individual elements is the same as in Figure 1. The arrow 
indicates the large loop in the neck of EibD. B) The YadA-like LPBR domain of EibD 
(blue) in comparison to the YadA (PDB ID: 1PH9, red). Chains B and C of the EibD are 
shown in surface representation. The surperimposition is shown from two different 
angles, from the side and viewed from the N-terminus. The large loop of EibD is 
indicated by an arrow. C) The -roll repeats of EibD LPBR domain. Conserved residues 
are indicated in colour. The LPBR repeats of EibD have the consensus sequence 
XSTALGXXA. D) The 120  right-handed rotation introduced by the neck. The rotation 
is shown for one monomer (in blue) and viewed from the N-terminus. The other two 
monomers are shown only from the beginning of the stalk, i.e. after the neck. E) The 
120  left-handed rotation at the saddle. The rotation is shown viewed from the N-
terminus for the monomer in blue; the other two monomers are shown from the saddle 
onwards. The dotted lines in panels D and E represent a 120  angle. F) Coordination of a 
chloride ion in the hydrophobic core of the stalk by asparagine residues (N407), N@d. G) 
Coordination of a chloride ion in the hydrophobic core of the stalk by threonine (T382) 
residues in the RTD motif, T@a. H) Coordination of a water oxygen by His residues 
(H421, H@d). I) Hydrogen bonding between glutamines (Q428) in the hydrophobic core 
(Q@d). H)  
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Figure S2, related to Figure 2. EibD cloning, truncation and point mutagenesis.  
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A) Binding of EibD fragments to IgG Fc and IgA. The upper panel shows an SDS-PAGE 
of cell lysates prepared from strains expressing different lengths of the EibD passenger 
domain. The lower panels show dot blots of the lysates probed with IgG Fc-HRP or IgA-
HRP (Jackson Immunoresearch). As controls, we included EibD27-441, which is known to 
bind both Ig classes (Leo and Goldman, 2009), and a lysate prepared from a strain 
containing only the vector (pET28b). The order of the samples in dot blots is the same as 
in the SDS-PAGE figures. 
Residue 161 represents the predicted beginning of the YadA-like region, and 303 the 
beginning of the coiled-coil stalk. Residue 418 lies well outside the predicted 
translocation unit, whereas 434 is located just outside the translocation unit and 441 is 
predicted to be part of the -helical linker within the transmembrane -barrel pore. We 
then cloned these fragments into an expression vector and produced the corresponding 
polypeptides in E. coli. To determine the minimal fragment still retaining Ig-binding 
activity, we prepared cell lysates of overnight cultures grown in autoinducing medium. 
Running the lysates in SDS-PAGE showed that all the fragments are produced as soluble 
protein in E. coli. 
 
B) Effect of C-terminal truncations on the Ig-binding activities of EibD. The upper panel 
shows an SDS-PAGE of lysates prepared from EibD161-418 and C-terminal truncations. 
The lower panels show dot blot of the lysates probed wiht IgG Fc-HRP or IgA-HRP 
(Jackson Immunoresearch). As controls, we included EibD27-150 and a lysate prepared 
from a strain containing only the vector (pET28b). The order of the samples in dot blot 
panels is the same as for the SDS-PAGE. The truncations EibD161-344 and EibD161-384 bind 
IgA, whereas the other two truncations do not, suggesting that binding site for IgG is at 
the very end of the stalk between residues 384 and 418. In our earlier experiments, 
EibD303-418 and EibD303-441, which lack the LPBR domain, did not give a detectable signal 
(Supplementary Figure 1) although both constructs should contain the IgA and IgG 
binding sites. This is possibly due to the stalks not forming stable trimers without the 
LPBR domain. 
 
C) Far-UV CD spectra of double and triple point mutants and stalk deletion mutants of 
EibD161-418. We diluted EibD161-418 and mutant proteins to a concentration of 
approximately 0.1 mg/ml in CD buffer (5 mM sodium phosphate pH 7.4, 5 mM NaCl). 
Far-UV CD spectra between 195 and 250 nm were recorded using a Jasco J-715 
instrument and a 1 mm cuvette at +20 C, with the final spectrum for each protein 
representing the average of five measurements. We converted the CD signal to molar 
ellipticity ( ) values using the formula  = CD/(n  c  l  10), where the CD signal is in 
millidegrees, n the number of residues, c the molar concentration of protein and l the 
length of the light path in centimetres. The spectrum of wt EibD161-418 is shown in blue. 
In addition to T415A-R416A-T417A, the only other mutants to show changes in their CD 
spectra were E341A-E344A and D387A-Y388A. The former showed wt binding, while 
the latter bound IgA like the wt, suggesting that the changes are local. For D387A-
Y388A, the change in CD signal is probably due to the removal of the Tyr residue. 
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D) SDS-PAGE of purification of EibD161-418 point mutants. For clarity, only the first 
mutated residue of each mutant is marked. a =  crude cell extract, b = eluate from Ni 
column, M = molecular weight marker (same as in panels A & B). 
 
E) The stalk of EibD alone is unstable. We purified four EibD proteins (EibD27-441, 
EibD161-418, EibD304-441 and EibD303-418) and measured their Ig-binding activities by dot 
blot (left-hand panels). The larger proteins, containing the LPBR domain, bound both 
IgG Fc and IgA strongly, whereas the shorter proteins consisting only of stalk, bound Igs 
poorly  the binding to IgA is barely detectable. The poor binding is probably due to the 
stalk dissociating. To verify this, we performed size exclusion chromatography coupled 
to multi-angle static light scattering and refractive index measurements on the largest and 
shortest EibD constructs. EibD27-441 eluted with an apparent molecular weight of 131.4  
0.26 kDa; the expected size of the trimer is 139.7 kDa. In contrast, EibD304-418 had an 
apparent molecular weight of only 33.2  0.17 kDa, suggesting the protein is mostly in a 
dimeric form (expected dimer size 29.8 kDa). Furthermore, the peak is asymmetric with 
tailing at the leading edge, indicating that there is an equilibrium between the dimer and 





Figure S3, related to Figure 4. Binding of EibD expressing cells to each other and 
immunoglobulins. 
 7 
A) TEM images showing zipper-like connection between EibD-expressing cells and 
intact cells binding membranes and membrane fragments from lysed cells. The scale bar 
corresponds to 100 nm in each image. 
B) Whole-cell binding assay of EibD10 and point mutants to HRP-conjugated IgA and 
IgG Fc. pET22 is the vector control. The point mutations K332A-K333A-Y334A and 
D387A-Y388A significanlty reduce binding to IgA and IgG Fc, respectively, compared 
to the wt. The Igs binding to the non-mutated site in the mutants gave strong signals, 
showing that the proteins are surface exposed and correctly folded. IgG Fc gave a weaker 
signal than IgA in these experiments, probably due to the binding site for IgG, located 
closer to the membrane, being less accessible. Error bars show the SEM from three 
replicate experiments. Statistical significance was estimated with Student's t-test (** p < 
0.001, *** p < 0.001). 
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Table S1 





EibD27-418 -gcgGCTAGCcagaatggtacatattcagtgttgca-  
-gcgAAGCTTttacagcgtacgggtattggctgc-  
EibD161-418 -gcggGCTAGCgatgcgaaagcctctggtgagt-  
Reverse: 5 - -gcgAAGCTTttacagcgtacgggtattggctgc-  
EibD161-441 Forward: -gcggGCTAGCgatgcgaaagcctctggtgagt-  
- gcgAAGCTTttagttacgcgtaccatcgcttaag-  
EibD303-418 -gcgaGCTAGCgcgg caactgttgg gcagttaa-  
-gcgAAGCTTttacagcgtacgggtattggctgc-  
EibD303-441 -gcgaGCTAGCgcgg caactgttgg gcagttaa-  
- gcgAAGCTTttagttacgcgtaccatcgcttaag-  
Eib-p1 5`-gacccatggtctccgattggcgcgattgatggccgcgtgacccgcaacacccagagc-  
Eib-p2 5`-gtgcgggtgttcgccgcaatcgctttgctgtttttttcaatgctctgggtgttgcgggtc-  
Eib-p3 5`-gattgcggcgaacacccgcaccctgcagcagcatagcgcgcgcctggatagccagcagcgccag-  
Eib-p4 5`-gaccatggtctcctcatttctttatggttttcgttaatctggcgctgctggctatcc-  
EibDStop150 -gtttcagcgtcgaagatTAAggggagaatg ggaagg-  
-ccttcccattctccccTTAatcttcgacgctgaaac-  
EibDStop308 -ggcaactgttgggcagTAAttaaaccggaaagttgg-  
-ccaactttccggtttaaTTActgcccaacagttgcc-  
EibDStop329 -taactgttgagtcagagTAAaagcagaaaaaatacac-  
-gtgtattttttctgcttTTActctgactcaacagtta-  
EibDStop344 -gcgaggttaacgaaTAAaaagttgaagcccgcac-  
-gtgcgggcttcaactttTTAttcgttaacctcgc-  










D336A-K338A -gcagaaaaaatacacaGCCcagGCGaccagcgaggttaacg-  
-cgttaacctcgctggtCGCctgGGCtgtgtattttttctgc-  
E341A-E344A -ccagaagaccagcGCGgttaacGCAaaagttgaagcc-  
-ggcttcaactttTGCgttaacCGCgctggtcttctgg-  
D384A-R385A -tctggcagaacaGCCGCTattgattatgcagttggtgccattg-  
-caatggcaccaactgcataAGCaatAGCgtctgttctgccaga-  
D387A-Y388A -ggcagaacagaccgtattGCTGCTgcagttggtgccattgatgg-  
-ccatcaatggcaccaactgcAGCAGCaatacggtctgttctgcc-  





- cgccttgctgtttttctcaatggaTGCCGCgttAGCggtgacacggcc-  
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E405A-K406A -cgtaacacgcaatccattGCGGCAaacagcaaggcgattgcag-  
-ctgcaatcgccttgctgttTGCCGCaatggattgcgtgttacg-  




Forward: ggcgattgcagccaatGCCGCTGCGctgtaaaagcttgcgggc-  
-gcccgcaagcttttacagCGCAGCGGCattggctgcaatcgcc-  
Restriction sites (GCTAGC for NheI and AAGCTT for HindIII) are capitalised. The 
introduced termination codon in the reverse primer is underlined. Introduced terminator 




SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
Cloning of EibD fragments. We amplified the DNA fragments corresponding to the 
fragments EibD27-418, EibD161-418, EibD161-441, EibD303-418 and EibD303-441 by polymerase 
chain reaction (PCR) using the plasmid pCS6364 (Sandt and Hill, 2000) as a template, 
and appropriate primers (Table S1). We then digested the PCR fragments with NheI and 
HindIII and ligated with the hexahistidine tag-encoding expression vector pET28b 
(Novagen), which had been digested with the same enzymes and dephosphorylated 
(enzymes from New England Biolabs). The ligation mixture was chemically transformed 
into E. coli DH5  and plated onto Luria-Bertani (LB) medium containing kanamycin at 
25 g/ml. The correctness of all clones was determined by sequencing. 
 
To produce the GCN4-EibD391-440 fusion, the sequence corresponding to EibD391-438 was 
amplified by a two-stage PCR: the central part of the fragment was first amplified using 
primers Eib-p2 and Eib-p3 and subsequently used as template in the next primer 
extension reaction using Eib-p1 and Eib-p4 as primers (primer sequences in Table S1). 
The produced fragment was purified, digested with BsaI and cloned into the vector pIBA-
GCN4tri-His (Hernandez Alvarez et al., 2008). The resulting construct comprises 
residues 391-438 of EibD fused in-register to GCN4pII-adaptors at its termini and a C-
terminal (His)6 linker. As the first two residues of the C-terminal GCN4pII adaptor are 
identical to residues 439 and 440 of EibD, the fused construct covers residues 391-440 of 
EibD in total. 
 
We were unable to see any expression of EibD on the cell surface using the plasmid 
pCS6364 (Sandt and Hill, 2000). Strong expression of the Eibs from their native 
promoter requires the regulatory factor ibrAB (Sandt et al., 2002); the strains we had 
lacked this factor. Therefore, we overexpressed EibD from the vector pET22. The coding 
sequence of EibD, excluding the signal peptide (residues 1-26) was amplified by 
polymerase chain reaction (PCR) using the plasmid pCS6364 as the template. We 
prepared two constructs: one including an N-terminal hexahistidine tag and one 
producing the native sequence. To produce the His-tagged version, we included 6 
sequences in the vector pET22b (Novagen). The product of this PCR reaction was 
inserted into pET22b by a PCR-based, restriction-free cloning method (van den Ent and 
Löwe, 2006). Insert-containing clones were identified by colony PCR, and the insert was 
sequenced to verify its correctness. The resulting constructs contained the EibD 
passenger and translocation domains fused to the PelB signal sequence already present in 
pET22b. pEibD9 had the N-terminal His tag inserted directly after the signal peptide 
cleavage site, so as to include the tag in the surface-expressed protein. pEibD10 had the 
EibD passenger fused directly to the signal peptide.  
 
Site-directed mutagenesis. 
from Stratagene. Briefly, we designed overlapping primers (Table S1) containing the 
desired nucleotide changes to produce either truncating or surface residue mutations of 
EibD161-418 or pEibD10. The entire plasmid, i.e. pET28b containing the sequence 
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corresponding to EibD161-418 (or EibD27-441 to produce the truncation ending at residue 
150), was amplified by PCR using mutation primer pairs, Pfu polymerase (Fermentas) 
and an extension temperature of 68 C. After PCR, the template plasmid was removed by 
digestion with DpnI (New England Biolabs). 5 l of the digested mix was directly 
transformed chemically into the cloning strain XL1-Blue and plated on LB + kanamycin 
(25 g/ml). The mutagenesis was verified by sequencing.  
 
Protein production and purification. For the expression of EibD fragments and surface 
residue mutants, verified plasmid DNA was transformed into E. coli BL21(DE3) and 
plated on LB + kanamycin (25 g/ml) supplemented with 0.5% (w/v) D-glucose. For 
small-scale expression cultures, we inoculated plasmid-containing bacteria into 5 ml of 
the autoinducing ZYP-5052 medium (Studier, 2005), containing 100 g/ml of 
kanamycin, and grew the cultures overnight at +37 C, during which time the protein was 
expressed.  
 
For medium-scale expression, we inoculated bacteria in 50 ml of autoinducing ZYP-5052 
medium (Studier, 2005) containing kanamycin as above in a 250 ml shake flask. The 
cultures were grown overnight at +37 C and harvested the following morning. 
 
For large-scale expression to produce protein for crystallisation, we first inoculated 
bacteria in 5 ml of the defined, protein expression-inhibiting medium PA-0.5G (Studier, 
2005), supplemented with 100 g/ml of kanamycin, and allowed the cultures to grow for 
approximately 7 hours. We then diluted the cultures 1:100 into the autoinducing ZYP-
5052 medium containing antibiotics as above into a total volume of 1 litre divided into 
two 2-litre shake flasks. The cultures were grown overnight as above.  
 
For surface expression of EibD for EM and autoagglutination assays, we transformed 
pEibD9 or pEibD10 into the the strain BL21(DE3)omp8 (Prilipov et al., 1998), which is 
optimised for high-level expression of outer membrane proteins. Cultures were grown in 
5 ml LB + ampicillin (100 g/ml) overnight at +37 C and diluted the following morning 
1:50 into fresh LB medium. The cultures were grown to OD600 ~0.5, at which time 
protein expression was induced by the addition of isopropylthiogalactoside to a final 
concentration of 1 mM (for EM, to ensure a high occupancy of EibD) or 0.2 mM (for 
autoagglutination assays, to minimise plasmid loss during incubation). Expression was 
continued for two hours before samples were taken for experiments.  
 
To produce crystallisable protein, we followed a purification protocol that has been 
described in detail before (Leo and Goldman, 2009). To purify mutant proteins, we used 
prepacked Protino® Ni-IDA 2000 columns (Macherey-Nagel) and performed cell lysis 
and purification according the man  
 
The GCN4-EibD391-440 fusion was expressed and purified under denaturing conditions 
using a Ni-NTA column (GE Healthcare) as described previously for His-tagged SadAK3 
(Hernandez Alvarez et al., 2008). Refolding was performed at 4°C by dialysis in 20 mM 
Tris/HCl, 400 mM NaCl, 5% glycerol, pH 7.5. Subsequently, the protein was 
concentrated and further purified using a size exclusion chromatography step on a 
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Superdex 75 column (GE Healthcare) equilibrated with 20 mM Tris/HCl, 400 mM NaCl, 
pH 7.5.  
 
Blocking experiments. We immobilised 1 g of either EibD27-441 or SpG (recombinant 
protein from Sigma, catalogue no. 19459) in 100 l of PBS for 1 hour onto microtitre 
plate wells. After blocking for 30 minutes with 5% bovine serum albumin (BSA; from 
Sigma) in PBS, we added a solution containing goat anti-mouse HPR-conjugated 
antibody (Santa Cruz Biotechnology) diluted to 1:8000 in 5% BSA in PBS that had 
previously been incubated for 30 minutes with a varying concentration of SpA 
(recombinant protein from Sigma, catalogue no. P7837). After washing four times with 
150 l of PBS-T, binding was detected by adding 100 l of substrate solution (TMB; 
from Thermo Scientific). Once colour had developed the reaction was stopped by the 
addition of 100 l of 2.5 M H2SO4, and absorbance was read at 450 nm. All steps were 
carried out at RT. For plotting, we took the signal from wells with no added SpA to be 
100% of binding and the background given by the BSA control to be 0% and calculated 
the percentage of antibody binding accordingly. 
 
SPR experiments. We examined the binding of Eibs to antibodies and antibody 
gA and IgG 
to a CM5 sensor chip using an amine coupling kit (both from GE Healthcare) according 
immobilised antibodies, we prepared dilutions of EibD in running buffer (PBS + 0.05% 
Tween20) at six concentrations between 1 nM and 600 nM of trimeric EibD. One of the 
concentrations (300 nM) was run in duplicate, and an additional zero-concentration 
sample was included. The dilutions were run over the chip surfaces at a flow rate of 25 
l/min at +25 C. The injection and dissociation steps were both 5 minutes, after which 
the surface was regenerated with 0.2% SDS. A wash step of 5 minutes with running 
buffer preceded the next injection. The results were analysed in the Biacore T100 
evaluation software (GE Healthcare). Kinetic analysis was hampered by the multivalent 
interactions between EibD and Igs, resulting in poor curve fits. Therefore, the data were 
fitted to the steady-state affinity model and Kd(app) values were calculated from the 
resulting Scatchard plots generated by the Biacore T100 software. Though the resulting 
fits to the model are not optimal, the data for each mutant were treated in the same way 
and are thus comparable. 
 
Electron microscopy. For TEM, EibD-expressing bacteria bacteria were sucked into 
cellulose capillary tubes, transferred to 150 µm planchettes filled with hexadecane, and 
high-pressure frozen in a Bal-Tec HPM 010 freezing device. The samples were freeze 
substituted (starting at -90 C down to -40 C) in 2% osmium tetroxide, 0.5% uranyl 
acetate, and 0.5% glutaraldehyde in acetone and finally embedded in Epon. Thin sections 
(90 nm) were cut and post-stained with uranyl acetate and lead citrate. The samples were 
imaged in a FEI Tecnai F20 at 200 kV and images captured using a Gatan Ultrascan 4000 
camera. For SEM, samples were fixed with 2.5% glutaraldehyde in PBS, postfixed with 
1% osmium tetroxide in phosphate-buffered saline, dehydrated in a graded series of 
ethanol and critical-point-dried from CO2. Finally the samples were sputter-coated with a 
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layer of 7 nm gold/palladium (Bal-Tec MED 010) and examined at 20 kV accelerating 
voltage in a Hitachi S-800 field emission scanning electron microscope. 
 
Whole-cell binding assay. To measure binding of whole cells to IgG and IgA, we used a 
modified solid-phase binding assay. We were unable to get a good signal from cells that 
were adsorbed onto a microtitre plate, probably because of the occlusion caused by EibD 
overexpression. Therefore, we used the following protocol: an overnight culture of EibD 
expressing cells or the vector control were diluted 1:10 in fresh medium and grown at 
+37 C until the OD600 value reached ~0.5. We then added BSA to 1% to block 
unspecific binding and continued growing for 15 minutes.  We added HRP-conjugated 
IgG Fc (1:5000) or HRP-IgA (1:2500, both from Jackson Immunoresearch) and IPTG to 
0.2 mM and continued growing for 30 minutes. We then collected the cells (10 min 4000 
x g), washed them twice with PBS to remove free antibody and resuspended in PBS at 
OD600 = 0.2. 100 l of this suspension was added to microtitre plate wells (Immulon 2 
HB, Thermo Scientific). The bacteria were allowed to adsorp for 1 hour at RT. After this, 
the wells were washed four times with 150 l PBS and binding was detected using TMB 
substrate as above.   
 
Autoagglutination and biofilm formation assays. For autoagglutination assays, 
BL21(DE3)omp8 cultures containing either pEibD10 or pET22 were grown as described 
above. After two hours of IPTG induction (see above), the cultures were taken out of the 
shaker and grown statically at +37 C. Every 15 minutes, a 60 l sample was taken from 
the surface of the culture and the OD600 value was measured. We repeated this procedure 
for a total of two hours.  
 
To assay for biofilm formation, EibD-expressing and control strains were inoculated in 1 
ml of ZYP-5052 (+ ampicillin 150 g/ml) in wells of a 24-well culture plate and grown 
overnight with gentle agitation (60 rpm) at +37 C. The following day, we removed the 
medium and washed the wells three times with 2 ml PBS. Following this, 2 ml of crystal 
violet solution (1% w/v) was added to the wells and incubated for 5 minutes at RT. After 
removing the crystal violet, we again washed three times as above. To elute the crystal 
violet from cells in biofilms, we added 2 ml of ethanol, incubated for two minutes with 
agitation, and then measured absorbances at 595 nm. 
 
Size exlusion chromatography with multi-angle static light scattering. To examine 
the dissociation of EibD, we performed size exclusion chromatography using a Shimadzu 
High Performance Liquid Chromatography unit with a Superdex 200 10/300 column (GE 
Healthcare). The column was equilibrated with TBS buffer and runs were performed at 
RT. Static light scattering and refractive index changes were measured using a Wyatt 
miniDAWN Treos and a Wyatt Optilab rEX detector, respectively. ~100 ug of protein 
was used for each run. 
 
